Mimedx Group Inc

NASDAQ:MDXG  
6.78
+0.26 (+3.99%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)786.98M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$60.26 Million
Adjusted EPS-$0.10
See more estimates
10-Day MA$6.29
50-Day MA$9.84
200-Day MA$10.34
See more pivots

Mimedx Group Inc Stock, NASDAQ:MDXG

1775 West Oak Commons Court NE, 1775 West Oak Commons Court NE, Marietta, Georgia 30062
United States of America
Phone: +1.770.651.9100
Number of Employees: 735

Description

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane; EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matri derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.